Magadh Sugar & Energy Limited (MAGADSUGAR.NS)
INR 683.2
(-0.21%)
INR 683.2
(-0.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.96 Billion | 9.53 Billion | 9.83 Billion | 9.27 Billion | 8.96 Billion | 7.36 Billion |
| Cost of Revenue | 7.42 Billion | 6.68 Billion | 7.63 Billion | 7.29 Billion | 6.42 Billion | 5.41 Billion |
| Gross Profit | 3.54 Billion | 2.85 Billion | 2.19 Billion | 1.97 Billion | 2.53 Billion | 1.95 Billion |
| Operating Expenses | 1.18 Billion | 1.79 Billion | 1.15 Billion | 1.01 Billion | 1.16 Billion | 1.1 Billion |
| Selling, General and Administrative Expenses | 252.18 Million | 178.08 Million | 48.92 Million | 52.63 Million | 44.58 Million | 33.43 Million |
| Research and Development Expenses | 46.34 Million | 69.17 Million | 44.97 Million | 54.5 Million | 39.9 Million | - |
| Other Expenses | 15.7 Million | 18.03 Million | 13.09 Million | 4.5 Million | 7.12 Million | 7.86 Million |
| Cost and Expenses | 8.05 Billion | 8.47 Billion | 8.78 Billion | 8.31 Billion | 7.59 Billion | 6.51 Billion |
| Operating Income | 2.9 Billion | 1.07 Billion | 1.03 Billion | 958.07 Million | 1.37 Billion | 847.08 Million |
| Interest Expense | 326.17 Million | 303.59 Million | 397.79 Million | 553.06 Million | 483.27 Million | 354.12 Million |
| Income Tax Expense | 401.82 Million | 268.29 Million | 204.31 Million | 152.3 Million | 246.04 Million | 196.52 Million |
| Earnings before Tax | 1.56 Billion | 770.9 Million | 664.49 Million | 423.11 Million | 1.07 Billion | 538.68 Million |
| Net Income | 1.16 Billion | 502.61 Million | 460.17 Million | 270.81 Million | 830.39 Million | 342.15 Million |
| Earnings Per Share Basic | 82.61 | 35.67 | 32.66 | 19.22 | 58.93 | 24.28 |
| Earnings Per Share Diluted | 82.61 | 35.67 | 32.66 | 19.22 | 58.93 | 24.28 |
| Weighted Average Shares Outstanding | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Gross Margin | 0.32 | 0.30 | 0.22 | 0.21 | 0.28 | 0.26 |
| EBIT Margin | 0.20 | 0.14 | 0.13 | 0.13 | 0.17 | 0.14 |
| Profit Margin | 0.11 | 0.05 | 0.05 | 0.03 | 0.09 | 0.05 |
| EBITDA | 2.17 Billion | 1.36 Billion | 1.28 Billion | 1.21 Billion | 1.89 Billion | 1.15 Billion |
| Earnings Before Tax Margin | 0.27 | 0.11 | 0.11 | 0.10 | 0.15 | 0.12 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 3.59 Billion | 2.88 Billion | 10.96 Billion | 2.18 Billion | 2.89 Billion | 3 Billion |
| Cost of Revenue | 3.03 Billion | 1.68 Billion | 7.9 Billion | 1.32 Billion | 2.2 Billion | 2.29 Billion |
| Gross Profit | 557.65 Million | 1.19 Billion | 3.06 Billion | 861.67 Million | 688.28 Million | 709.03 Million |
| Operating Expenses | 270.3 Million | 454.1 Million | 1.18 Billion | 311.99 Million | 419.88 Million | 390.44 Million |
| Selling, General and Administrative Expenses | 270.3 Million | 454.1 Million | - | 311.99 Million | 225.03 Million | 196.74 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.97 Million | 3.54 Million | 15.7 Million | 6.76 Million | 2.88 Million | 2.5 Million |
| Cost and Expenses | 3.3 Billion | 2.14 Billion | 9.08 Billion | 1.63 Billion | 2.62 Billion | 2.68 Billion |
| Operating Income | 287.35 Million | 739.73 Million | 1.87 Billion | 549.68 Million | 271.28 Million | 321.08 Million |
| Interest Expense | 131.34 Million | 111.83 Million | 326.17 Million | 35.14 Million | 65.9 Million | 113.29 Million |
| Income Tax Expense | 44.72 Million | 162.64 Million | 401.82 Million | 132.21 Million | 54.57 Million | 52.39 Million |
| Earnings before Tax | 158.98 Million | 631.43 Million | 1.56 Billion | 521.3 Million | 205.38 Million | 207.79 Million |
| Net Income | 114.25 Million | 468.79 Million | 1.16 Billion | 389.08 Million | 150.81 Million | 155.39 Million |
| Earnings Per Share Basic | 8.11 | 33.27 | - | 27.61 | 10.70 | 11.03 |
| Earnings Per Share Diluted | 8.11 | 33.27 | - | 27.61 | 10.70 | 11.03 |
| Weighted Average Shares Outstanding | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Gross Margin | 0.16 | 0.41 | 0.28 | 0.39 | 0.24 | 0.24 |
| EBIT Margin | 0.10 | 0.28 | - | 0.28 | 0.12 | 0.13 |
| Profit Margin | 0.03 | 0.16 | 0.11 | 0.18 | 0.05 | 0.05 |
| EBITDA | 352.73 Million | 804.09 Million | - | 613.24 Million | 334.61 Million | 384.08 Million |
| Earnings Before Tax Margin | 0.08 | 0.26 | 0.17 | 0.25 | 0.09 | 0.11 |
EXCELINDUS
AARTIPHARM
ALB
DKM
4265
TPSRF